Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables RefundsShares Outstanding
Ratios

KalVista Pharmaceuticals (KALV) Shares Issued: 2014-2024

Historic Shares Issued for KalVista Pharmaceuticals (KALV) over the last 3 years, with Oct 2024 value amounting to $295,000.

  • KalVista Pharmaceuticals' Shares Issued rose 130.47% to $295,000 in Q4 2024 from the same period last year, while for Oct 2024 it was $99.8 million, marking a year-over-year increase of 745.36%. This contributed to the annual value of $55.9 million for FY2025, which is 42.33% down from last year.
  • According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Shares Issued is $295,000, which was down 90.17% from $3.0 million recorded in Q3 2024.
  • KalVista Pharmaceuticals' 5-year Shares Issued high stood at $96.3 million for Q2 2024, and its period low was $46,000 during Q3 2020.
  • Over the past 2 years, KalVista Pharmaceuticals' median Shares Issued value was $295,000 (recorded in 2024), while the average stood at $20.0 million.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 99.60% in 2020, then soared by 1,370.59% in 2024.
  • Over the past 3 years, KalVista Pharmaceuticals' Shares Issued (Quarterly) stood at $46,000 in 2020, then reached $128,000 in 2023, then soared by 130.47% to $295,000 in 2024.
  • Its last three reported values are $295,000 in Q4 2024, $3.0 million for Q3 2024, and $96.3 million during Q2 2024.